Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Orazi

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Leukemia|June 1, 1993
Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessmentA Orazi, G Cattoretti, D Soligo, et al.
American Journal of Clinical Pathology|April 1, 1994
CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemiaA Orazi, R S Neiman, H Cualing, et al.
Pediatric Hematology and Oncology|January 1, 1988
Acute monoblastic leukemia as a second malignancy following chemotherapy for osteogenic sarcoma: a case reportA Orazi, G Sozzi, D Delia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 1997
013 (CD99) positivity in hematologic proliferations correlates with TdT positivityP B Robertson, R S Neiman, S Worapongpaiboon, et al.
American Journal of Clinical Pathology|March 1, 1997
Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimensA Orazi, M Albitar, N A Heerema, et al.
Neurosurgery|February 16, 2002
Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome studyT H Schwartz, R Rhiew, S R Isaacson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 1994
Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNAH Budke, A Orazi, R S Neiman, et al.
Journal of Pediatric Surgery|August 7, 1998
Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosisQ Liu, M Kabeer, M Callahan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 1993
Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsiesA Orazi, G Cattoretti, N A Heerema, et al.
American Journal of Clinical Pathology|February 1, 1995
In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsiesA Orazi, M S Gordon, K John, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Leukemia|June 1, 1993
Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessmentA Orazi, G Cattoretti, D Soligo, et al.
American Journal of Clinical Pathology|April 1, 1994
CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemiaA Orazi, R S Neiman, H Cualing, et al.
Pediatric Hematology and Oncology|January 1, 1988
Acute monoblastic leukemia as a second malignancy following chemotherapy for osteogenic sarcoma: a case reportA Orazi, G Sozzi, D Delia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 1997
013 (CD99) positivity in hematologic proliferations correlates with TdT positivityP B Robertson, R S Neiman, S Worapongpaiboon, et al.
American Journal of Clinical Pathology|March 1, 1997
Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimensA Orazi, M Albitar, N A Heerema, et al.
Neurosurgery|February 16, 2002
Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome studyT H Schwartz, R Rhiew, S R Isaacson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 1994
Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNAH Budke, A Orazi, R S Neiman, et al.
Journal of Pediatric Surgery|August 7, 1998
Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosisQ Liu, M Kabeer, M Callahan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 1993
Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsiesA Orazi, G Cattoretti, N A Heerema, et al.
American Journal of Clinical Pathology|February 1, 1995
In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsiesA Orazi, M S Gordon, K John, et al.
Pageof 10